Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Medipharm Labs Corp

LABS.TO ✗ NOT COMPLIANT ☆ Track — members

TSX · Healthcare · Pharmaceuticals ·

Canada Micro Cap Analyst: N/A

Last Close

$0.05

▲ +0.00%

Market Cap $23.23M · Vol 11.66K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$23.23M

Micro Cap

Div Yield

N/A

EPS Growth

+60.57%

YoY

RSI (14)

33.33

Momentum

Beta

0.84

vs Market

52W High

$0.07

25.83% below

52W Low

$0.04

27.41% above

Volume

11.66K

Avg 148.24K

P/B

0.77

Price-to-book

ROE

N/A

Return on equity

Free Float

87.01%

Public shares

Shariah Compliance8 STANDARDS

✗ Medipharm Labs Corp (LABS.TO) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LABS.TO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.25%

+0.00%

+7.14%

YTD

+15.38%

+7.14%

-13.02%

-77.61%

Financials & Valuation

TTM · Annual

Total Revenue	$32.88M
Net Income	$-6,023,754.00
Revenue Growth (YoY)	-15.45%
Gross Margin	27.02%
Operating Margin	-22.78%
Net Profit Margin	-18.32%
ROE	N/A
ROA · ROIC	-16.62% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.60
P/B	0.77
P/FCF	N/A
EPS Growth	+60.57%
Outstanding Shares	427.18M

Technical Indicators

50-Day SMA	$0.05
200-Day SMA	$0.05
RSI (14)	33.33
Beta	0.84
52-Week High	$0.07
52-Week Low	$0.04

Volume Today	11.66K
Avg Daily Volume (30D)	148.24K
Relative Volume	0.08x
Volatility (10D)	45.64
Volatility (30D)	62.50
Free Float	87.01%

Analyst Consensus

N/A

Current Price $0.05

Mean Target N/A

52W Low$0.04 52W High$0.07

Current

Target

$0.04 $0.07

Current Analyst target

· 1 analysts

Identifiers

ExchangeTSX

FIGIBBG00HZZLFX3

ISINCA58504D1006

CountryCanada

Sub-IndustryRecreational Pharmaceuticals

Earnings DateNov 11, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -0.88% JNJ Johnson & Johnson -1.15% ABBV Abbvie Inc -1.44% MRK Merck & Co Inc -1.32% NVS Novartis AG -1.90%

Company Profile

MediPharm Labs Corp. is a Canada-based pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. It develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets. The Company cultivates and processes cannabis to sell as dried flower, pre-roll and other cannabis products for adult use, medical, and international markets. The Company also provides GMP flower sourcing, packaging, and distribution services for select international clients. Its wholly owned subsidiary Harvest Medicine Inc. operates medical clinics in Canada that provide medical cannabis patients with physician consultations for medical cannabis education and prescriptions. Its international subsidiaries include Beacon Medical Germany GmbH and Beacon Medical Australia Pty Ltd.